Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale.
Yamaguchi
Kouji
K
Department of Maxillofacial Surgery, Tohoku University Graduate School of Dentistry, Aoba-ku, Sendai, Japan.
Oizumi
Takefumi
T
Funayama
Hiromi
H
Kawamura
Hiroshi
H
Sugawara
Shunji
S
Endo
Yasuo
Y
D000368:Aged; D000369:Aged, 80 and over; D001667:Binding, Competitive; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D004164:Diphosphonates; D012968:Etidronic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D008070:Lipopolysaccharides / Q000378:metabolism; D008336:Mandibular Diseases / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism; D009584:Nitrogen; D010019:Osteomyelitis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D010020:Osteonecrosis / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D000068296:Risedronic Acid; D017556:Technetium Compounds; D014081:Tooth Extraction / Q000009:adverse effects
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D018836:Inflammation Mediators; D008070:Lipopolysaccharides; D019275:Radiopharmaceuticals; D017556:Technetium Compounds; C029045:technetium Tc 99m diphosphonate; D000068296:Risedronic Acid; D012968:Etidronic Acid; D009584:Nitrogen